Serina Therapeutics is located at the HudsonAlpha Institute for Biotechnology
Serina Therapeutics, Inc.
601 Genome Way
Huntsville, Alabama 35806
Phone | 256.327.0566
Email | email@example.com
Dr. Standaert joined the University of Alabama at Birmingham faculty in July of 2006 and is the John N. Whitaker Professor and Chair of the Department of Neurology. He serves as Director of the Division of Movement Disorders, the Director of the APDA Advanced Center for Parkinson Research at UAB, and is the Director of the Center for Neurodegeneration and Experimental Therapeutics. He sees patients in a weekly clinic and oversees many clinical trials for new treatments of Parkinson’s disease. He is a member of the Scientific Advisory Boards of the Michael J. Fox Foundation for Parkinson Research, the American Parkinson Disease Association, and the Bachmann-Strauss Dystonia & Parkinson Foundation.
Dr. Standaert graduated from Harvard College in 1982, and received his M.D. and Ph.D. degrees from Washington University in St. Louis. He completed a one-year internship in Medicine followed by a three-year Neurology residency at the University of Pennsylvania. He was appointed a Howard Hughes Medical Institute Physician Research Fellow, and completed a three-year research and clinical fellowship in Neurology (Movement Disorders) at Harvard Medical School and Massachusetts General Hospital in 1995. He subsequently joined the faculty at MGH where he served as Director of the MGH/MIT Udall Center of Excellence in PD Research as well as a Chair of the MGH Institutional Review Board (IRB).